# Pleno Inc.

> Pleno Inc. is a San Diego multi-omic instrument company rebuilding the economics of biological target detection. Its RAPTOR platform, powered by proprietary Hypercoding technology borrowed from telecommunications signal processing, can detect up to 10,000 targets in a single sample at PCR-like speed and cost. Founded by serial entrepreneur Pieter van Rooyen, the company is moving from R&D into commercial launch with backing from Deerfield Management and Foresite Capital.

- **Founded:** 2020
- **Headquarters:** San Diego, United States
- **Founders:** Pieter van Rooyen (Founder (former CEO))
- **Team size:** ~40 employees
- **Products:** RAPTOR Instrument Platform, Hypercoding Technology
- **Notable:** Raised roughly $80M total across Pre-Series A, Series A, and Series B rounds, Built RAPTOR to detect up to 10,000 targets per sample with a PCR-like ~2-hour workflow, Recruited Dr. Vik Vaz, M.D. (formerly Illumina, BCG, McKinsey) as CEO and President in December 2024

## Products & services

- **RAPTOR Instrument Platform** — A multi-omic detection instrument with a PCR-like workflow that simplifies complex assays. Capable of detecting up to 10,000 targets per sample and processing up to 10,000 samples per day across oncology, pharmacogenomics, genotyping, proteomics, and agrigenomics applications.
- **Hypercoding Technology** — Proprietary detection chemistry and algorithms that apply telecommunications signal-processing and error-correction techniques (conceptually similar to CDMA code multiplexing) to biology, assigning each molecular target a unique code so thousands of targets can be multiplexed and read at once.

## Achievements

- Raised roughly $80M total across Pre-Series A, Series A, and Series B rounds
- Built RAPTOR to detect up to 10,000 targets per sample with a PCR-like ~2-hour workflow
- Recruited Dr. Vik Vaz, M.D. (formerly Illumina, BCG, McKinsey) as CEO and President in December 2024
- Signed first commercial agreement with Slopes Bio in August 2025
- Founded by Pieter van Rooyen, whose prior company Edico Genome was acquired by Illumina (its DRAGEN tech now ships in Illumina sequencers)

## Latest updates

- **2025-08** — Announced first commercial agreement with Slopes Bio Inc., marking the official commercial launch of the RAPTOR platform.
- **2024-12** — Closed $25M Series B and appointed Dr. Vik Vaz, M.D. as CEO and President.
- **2024-01** — Deployed RAPTOR platform for use with BioLegend's TotalSeq antibodies.

## Links

- Website: https://plenoinc.com
- LinkedIn: https://www.linkedin.com/company/pleno-inc
- Twitter/X: https://twitter.com/Pleno_Inc

---

Profile page: https://yespress.io/pleno-inc
Published by YesPress — https://yespress.io
Last updated: 2026-06-13